Q4283 HCPCS code: Biovance tri-layer or biovance 3l, per square centimeter (add-on, list separately in addition to primary procedure)
Q4283 is the HCPCS Level II code for biovance tri-layer or biovance 3l, per square centimeter (add-on, list separately in addition to primary procedure). In 2024 Medicare paid an average of $990.07 per service for Q4283 across 25,177 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume rose 198% from 2023 to 2024 (8,459 to 25,177 services). In 2024, about 157 clinicians billed Medicare for Q4283 for 355 beneficiaries; Florida, New Jersey, Oklahoma accounted for 66% of services.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 11 — Priced using national relative value units (Physician Fee Schedule) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2026-01-01 |
Who bills Q4283 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 157 |
| Medicare beneficiaries | 355 |
| States with claims | 9 |
| Share of services in top 3 states (Florida, New Jersey, Oklahoma) | 66% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for Q4283, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 8,459 | 89 | $1,486.68 | $1,184.51 |
| 2024 | 25,177 | 355 | $1,242.70 | $990.07 |
States with the most Q4283 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 6,321 | $997.92 |
| New Jersey | 4,068 | $1,106.35 |
| Oklahoma | 2,251 | $1,179.00 |
| California | 1,780 | $843.03 |
| New York | 1,184 | $1,043.74 |
What changed for Q4283
- January 2026: Descriptor revised (Was: Biovance tri-layer or biovance 3l, per square centimeter)
- 2023-07-01: Q4283 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q4283?
Q4283 is the HCPCS Level II code for biovance tri-layer or biovance 3l, per square centimeter (add-on, list separately in addition to primary procedure). Short descriptor: "Biovance tri or 3l, sq cm".
How much does Medicare pay for Q4283?
In 2024, the average Medicare payment was $990.07 per service (average allowed $1,242.70).
Does Medicare cover Q4283?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related Q42 codes
- Q4200 — Skin te, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4201 — Matrion, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4202 — Keroxx (2.5g/cc), 1cc
- Q4203 — Derma-gide, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4204 — Xwrap, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4205 — Membrane graft or membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4206 — Fluid flow or fluid gf, 1 cc
- Q4207 — Carbon life, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4208 — Novafix, per square cenitmeter (add-on, list separately in addition to primary procedure)
- Q4209 — Surgraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4210 — Axolotl graft or axolotl dualgraft, per square centimeter
- Q4211 — Amnion bio or axobiomembrane, per square centimeter (add-on, list separately in addition to primary procedure)
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q4283
- Watch Q4283 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q4283
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.